Stephen J. Manzano's most recent trade in Amneal Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 135,136 Performance-Based Restricted Stock Units done . Disclosure was reported to the exchange on March 1, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc... | Stephen J. Manzano | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 135,136 | 135,136 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Stephen J. Manzano | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 67,568 | 67,568 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Stephen J. Manzano | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2021 | 16,490 | 16,490 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Stephen J. Manzano | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2021 | 16,490 | 49,473 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Stephen J. Manzano | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.39 per share. | 27 Feb 2021 | 5,796 | 10,694 (0%) | 0% | 5.4 | 31,240 | Class A Common Stock |